Dr. Eduardo Sotomayor to lead Malignant Hematology Program
Tampa, FL— Dr. Alan F. List, formerly the division chief of Malignant Hematology at Moffitt Cancer Center, has been named Executive Vice President, Physician-in-Chief. He will take over for the retired Dr. Clifford Schold Jr.
“It is an honor and privilege to serve in this new role at the cancer center,” List said.
List earned his medical degree from the University of Pennsylvania and completed an internship and residency in internal medicine at Good Samaritan Medical Center in Phoenix. He completed a fellowship in hematology and in medical oncology at Vanderbilt University Medical Center.
After fellowship training, List joined the faculty of the Arizona Cancer Center, where he served as the head of the Leukemia and BMT Programs and the associate center director for clinical research before joining Moffitt in 2003.
Eduardo Sotomayor is the new chief of the Malignant Hematology division. He has been part of the Malignant Hematology faculty since 1999. Sotomayor earned his medical degree from Federico Villarreal University School of Medicine in Lima, Peru. He then completed a research fellowship in immunology, as well as a residency in internal medicine, at the University of Miami School of Medicine. He received his training in oncology at the Johns Hopkins Oncology Center.
Dr. Sotomayor has made important contributions to the field of cancer immunology and immunotherapy, and his research has been continuously funded by several grants from the National Institutes of Health, where he serves as standing member of the Cancer Immunotherapy and Immunopathology Study Section.
“I feel privileged in assuming this leadership position after Dr. List, who has been instrumental in building a state-of-the-art translational program in malignant hematology at Moffitt,” Sotomayor said.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer, as well as for ear, nose and throat. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.